PTPN2 and inflammatory bowel disease: Our novel findings open the way for future studies examining the unexpected decrease in TC-PTP+/− protein levels following DSS treatment, as well as identifying specific mechanisms leading to the loss of epithelial cells in this animal model of IBD.